Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
3.300
-0.300 (-8.33%)
Aug 24, 2026, 11:10 AM HKT
-41.59% (1Y)
| Market Cap | 639.70M -41.6% |
| Revenue (ttm) | 74.40M -38.0% |
| Net Income | -94.29M |
| EPS | -0.49 |
| Shares Out | 193.85M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,800 |
| Open | 3.600 |
| Previous Close | 3.600 |
| Day's Range | 3.300 - 3.600 |
| 52-Week Range | 3.300 - 8.400 |
| Beta | 0.50 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |